Discovery and development of First-in-class/Best-in-class small molecule innovative drug
Novel discovery platforms of targeted protein degradation (TPD), with a commitment on areas of autoimmunity and oncology, leveraging new unmet medical needs and the synergistic combinations to transform patients life.